These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32714104)

  • 1. Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions.
    Grifoni A; Sidney J; Zhang Y; Scheuermann RH; Peters B; Sette A
    SSRN; 2020 Feb; ():3541361. PubMed ID: 32714104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.
    Grifoni A; Sidney J; Zhang Y; Scheuermann RH; Peters B; Sette A
    Cell Host Microbe; 2020 Apr; 27(4):671-680.e2. PubMed ID: 32183941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
    Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
    Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of
    Hassan MM; Sharmin S; Hong J; Lee HS; Kim HJ; Hong ST
    Open Life Sci; 2021; 16(1):630-640. PubMed ID: 34222663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
    Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
    Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Candidate CD8
    Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
    Viruses; 2021 May; 13(6):. PubMed ID: 34073934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.
    Robson B
    Comput Biol Med; 2020 Apr; 119():103670. PubMed ID: 32209231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
    Tian X; Li C; Huang A; Xia S; Lu S; Shi Z; Lu L; Jiang S; Yang Z; Wu Y; Ying T
    Emerg Microbes Infect; 2020; 9(1):382-385. PubMed ID: 32065055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].
    Shi Y; Wang N; Zou QM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):614-619. PubMed ID: 32234130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
    Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.
    Kiyotani K; Toyoshima Y; Nemoto K; Nakamura Y
    J Hum Genet; 2020 Jul; 65(7):569-575. PubMed ID: 32372051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of multi-epitope vaccine candidate against SARS-CoV-2: a
    Abraham Peele K; Srihansa T; Krupanidhi S; Ayyagari VS; Venkateswarulu TC
    J Biomol Struct Dyn; 2021 Jul; 39(10):3793-3801. PubMed ID: 32419646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
    Dong S; Sun J; Mao Z; Wang L; Lu YL; Li J
    J Med Virol; 2020 Sep; 92(9):1542-1548. PubMed ID: 32181901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
    Baruah V; Bose S
    J Med Virol; 2020 May; 92(5):495-500. PubMed ID: 32022276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
    Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity.
    Mathew S; Fakhroo AD; Smatti M; Al Thani AA; Yassine HM
    Immunogenetics; 2022 Apr; 74(2):213-229. PubMed ID: 35006282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.